Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Predict S.P.A. Class B ( (IT:PRE) ) is now available.
Predict S.p.A. reported a slight decline in revenues for 2024, totaling €6.63 million compared to €7.19 million in 2023, primarily due to delays in public funding and the absence of tax incentives for private clients. Despite the revenue drop, the company improved its profitability, with an EBITDA margin increasing to 12.2% from 11.2% the previous year, reflecting effective cost optimization and operational efficiency. The company plans to continue investing in strategic areas to strengthen its competitive position and ensure sustainable growth.
More about Predict S.P.A. Class B
Predict S.p.A. is an innovative SME operating in the healthcare sector, focusing on in vivo diagnostics. The company specializes in distributing ultrasound and radiological equipment and developing advanced technologies in breath analysis and digital healthcare.
YTD Price Performance: -25.37%
Average Trading Volume: 8,564
Technical Sentiment Signal: Strong Buy
Learn more about PRE stock on TipRanks’ Stock Analysis page.